VIVOSIM LABS ($VIVS) is expected to release its quarterly earnings data on Monday, August 10th before market open, per Finnhub. Analysts are expecting revenue of $47,940 and earnings of -$0.19 per share.
You can see Quiver Quantitative's $VIVS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
VIVOSIM LABS Hedge Fund Activity
We have seen 6 institutional investors add shares of VIVOSIM LABS stock to their portfolio, and 8 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC removed 19,449 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $27,812
- GEODE CAPITAL MANAGEMENT, LLC added 16,201 shares (+78.5%) to their portfolio in Q1 2026, for an estimated $23,167
- GOLDMAN SACHS GROUP INC added 16,072 shares (+inf%) to their portfolio in Q1 2026, for an estimated $22,982
- TWO SIGMA INVESTMENTS, LP removed 11,830 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $16,916
- NORTHERN TRUST CORP removed 10,535 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $15,065
- CITIGROUP INC removed 6,504 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $6,959
- UBS GROUP AG added 936 shares (+5850.0%) to their portfolio in Q1 2026, for an estimated $1,338
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
